Advanced Filters
noise

Migraine Clinical Trials

A listing of Migraine medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 159 clinical trials

Migraines Accepted Laser Acupuncture Compared in Blood Test of MMP2 and CGRP

Aims To investigate the efficacy of laser-acupuncture for the severity of primary headache and comorbidities, and the Lab data examination. Methods In this hospital-based prospective single blind randomized sham-controlled study, patients over 18 years old with primary headache will be randomly divided into two treatment arms including laser-acupuncture and sham-controlled …

18 years of age All Phase N/A
N Nicholas Zumba

Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines

The main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic migraine intensity, frequency, and duration.

18 - 75 years of age All Phase 2
F Francescantonio Cammarota

Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine

The investigators aim to assess and compare neurophysiological and biochemical changes induced by a 3-month treatment with atogepant (60 mg daily) in patients with high-frequency episodic migraine (8-14 monthly migraine days). Evaluations will include neurophysiological assessments (High-Density EEG, nociceptive reflexes, and visual evoked potentials) and biomolecular profiling (gene expression of …

18 - 70 years of age All Phase N/A
S Sonja Antic

Trial Designs for Evaluating Migraine Treatment

The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, advanced balanced placebo design, patients with episodic migraine will receive six treatment conditions in a randomized order.

18 - 65 years of age All Phase N/A
S Samar Ashrafi, PharmD

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.

18 years of age All Phase 3

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age.

6 - 11 years of age All Phase 4
J Julie CONTENTI

Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx)

Migraine is a common pathology, affecting around 12% of the general population, up to 25% in some cohorts, as well as a significant part of the reasons for emergency room visits. Unlike cluster headaches, the use of high-flow oxygen therapy has not yet been validated in patients with migraine. However, …

18 years of age All Phase 4
L Leann Rodriguez

Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence …

18 - 85 years of age All Phase 0
A Ayushi D Balan, BA, BS

Emgality for Migraine in Breastmilk

The goal of this project is to evaluate galcanezumab transfer into maternal breastmilk, and to evaluate infant (growth, development, constipation, colic, infections) and maternal (headache) outcomes for dyads in which the mother was treated with galcanezumab and to compare outcomes for infants who were or were not breastfed after maternal …

18 - 45 years of age Female Phase N/A
P Piero Barbanti, Prof, MD

EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.

The object of this study is to assess the effectiveness, safety, and tolerability of eptinezumab in a real life migraine population.

18 - 75 years of age All Phase N/A

Simplify language using AI